Quest Jun 3, 2020 BFOR Study Uses Digital Tools to Facilitate Population BRCA Screening in Ashkenazi Jewish Community Aug 1, 2019 Novartis Launches Free BRAF Testing Program Hoping to Close Access Gaps, Maintain Market Lead Premium Jun 22, 2017 Quest Diagnostics to Expand Advanced Cancer Care to Community Oncologists Through Recent Acquisitions Premium Apr 13, 2017 Panel Test May Cost-Effectively Improve Life Expectancy for Women at High Risk of Breast Cancer Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer
